Companies/EU/969500XPWN2D

GENFIT

Last · Paris€7.96+0.13 (+1.66%)live · yahoo · 2h ago
Vol 99.0K ≈ 784.1K
Market cap€398.2M50.0M sh
P/E · TTM-4.2fwd 85.1 · eps -2.04 · loss
Beta1.19vs S&P 500
Div yield0.00%annual · TTM
52w range
€3.40€15.48
Volume102.3Ksession

Issuer

Legal nameGENFIT
HQEurope (EU)
ListingEU 969500XPWN2D
ISINFR0004163111
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyEUR
Entity registrylei:969500XPWN2DMZQA5X73
Employees188
AddressGenfit SA Parc Eurasante 59120, Loos +33 3 20 16 40 00
Headline financial metrics
Revenue€70.9M
Operating income€3.3M
Net income€1.5M
Free cash flow€14.6M
Operating margin4.6%
Net margin2.1%
Return on equity2.2%
Period2024
Loading chart…

OpenFilings analyst

Our analyst

ANNUAL · 2026-04-03

From latest ANNUAL · 2026-04-03

  • Operating Cf Burn
  • Net Margin Sharply Negative

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -120.9%

Press & signals

3 of 9 recent
  • GlobeNewswire

    GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update

  • GlobeNewswire

    GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF

  • GlobeNewswire

    GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
2026-10-122026-10-120
2026-10-072026-10-070
2026-10-052026-10-050
2026-10-052026-10-050
2026-10-022026-10-020